120 related articles for article (PubMed ID: 35843830)
1. Clinical significance and safety of combined treatment with chemotherapy and pulmonary rehabilitation regarding health-related quality of life and physical function in nontuberculous mycobacterial pulmonary disease.
Omatsu S; Tabusadani M; Yamane K; Takao S; Kuroyama Y; Matsumura Y; Mori K; Ono K; Kawahara K; Senjyu H; Kozu R
Respir Investig; 2022 Sep; 60(5):674-683. PubMed ID: 35843830
[TBL] [Abstract][Full Text] [Related]
2. Is the Leicester Cough Questionnaire useful for nontuberculous mycobacterial lung disease?
Takao S; Tabusadani M; Yamane K; Kakuta T; Kuroyama Y; Mori K; Ono K; Omatsu S; Kawahara K; Toyoda Y; Senjyu H
Respir Investig; 2021 Jan; 59(1):120-125. PubMed ID: 32800755
[TBL] [Abstract][Full Text] [Related]
3. Incremental Shuttle Walk Distance as an Indicator for Functional Exercise Capacity of Pre-Surgical Patients with Nontuberculous Mycobacterial Lung Disease.
Kuroyama Y; Tabusadani M; Omatsu S; Shiraishi Y; Senjyu H
Tohoku J Exp Med; 2020 Jan; 250(1):43-48. PubMed ID: 31996491
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal significance of six-minute walk test in patients with nontuberculous mycobacterial pulmonary disease: an observational study.
Morita A; Yagi K; Asakura T; Namkoong H; Sato Y; Ogawa T; Kusumoto T; Suzuki S; Tanaka H; Lee H; Okamori S; Azekawa S; Nakagawara K; Kaji M; Nagao G; Funatsu Y; Kimizuka Y; Kamata H; Nishimura T; Ishii M; Fukunaga K; Hasegawa N
BMC Pulm Med; 2023 Jul; 23(1):247. PubMed ID: 37415094
[TBL] [Abstract][Full Text] [Related]
5. Physical Function and Health-Related Quality of Life after Surgery for Nontuberculous Mycobacterial Pulmonary Disease: A Prospective Cohort Study.
Kuroyama Y; Tabusadani M; Omatsu S; Hiramatsu M; Shiraishi Y; Kimura H; Senjyu H
Ann Thorac Cardiovasc Surg; 2022 Apr; 28(2):103-110. PubMed ID: 34433729
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life associates with clinical parameters in patients with NTM pulmonary disease.
Kawahara K; Tabusadani M; Yamane K; Takao S; Kuroyama Y; Matsumura Y; Mori K; Ono K; Omatsu S; Furuuchi K; Fujiwara K; Morimoto K; Kimura H; Senjyu H
Int J Tuberc Lung Dis; 2021 Apr; 25(4):299-304. PubMed ID: 33762074
[No Abstract] [Full Text] [Related]
7. Nontuberculous mycobacterial pulmonary disease diagnosed by two methods: a prospective cohort study.
Kim HJ; Lee JH; Yoon SH; Kim SA; Kim MS; Choi SM; Lee J; Lee CH; Han SK; Yim JJ
BMC Infect Dis; 2019 May; 19(1):468. PubMed ID: 31126235
[TBL] [Abstract][Full Text] [Related]
8. Influence of chronic sputum symptoms on quality of life in patients with nontuberculous mycobacterial pulmonary disease: A cross-sectional study.
Yamane K; Furuuchi K; Tabusadani M; Takao S; Kuroyama Y; Matsumura Y; Mori K; Ono K; Kawahara K; Omatsu S; Toyoda Y; Fujiwara K; Morimoto K; Senjyu H
Respir Investig; 2022 Mar; 60(2):277-283. PubMed ID: 34764045
[TBL] [Abstract][Full Text] [Related]
9. Improvement in Health-Related Quality of Life Following Antibiotic Treatment in Nontuberculous Mycobacterial Pulmonary Disease: Initial Analysis of the NTM-KOREA Cohort.
Kwak N; Henkle E; Hwang H; Jeon D; Jhun BW; Jo KW; Kang YA; Kim HJ; Kim JY; Kim YR; Kwon YS; Lee JH; Mok J; Park Y; Shim TS; Sohn H; Whang J; Yim JJ
Clin Infect Dis; 2024 Jun; 78(6):1690-1697. PubMed ID: 38563246
[TBL] [Abstract][Full Text] [Related]
10. Decreased incremental shuttle walk test distance characterized by fibrocavitary lesions in non-tuberculous mycobacterial pulmonary disease.
Ono K; Tabusadani M; Yamane K; Takao S; Mori K; Matsumura Y; Kuroyama Y; Kawahara K; Omatsu S; Furuuchi K; Fujiwara K; Morimoto K; Kimura H; Senjyu H
Expert Rev Respir Med; 2022 Apr; 16(4):469-475. PubMed ID: 35245168
[TBL] [Abstract][Full Text] [Related]
11. [The clinical analysis of chronic obstructive pulmonary disease patients complicated with nontuberculous mycobacterial pulmonary disease].
Sun YX; Shao C; Li S; Xu K; Huang H; Xu ZJ
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Nov; 42(11):826-831. PubMed ID: 31694092
[No Abstract] [Full Text] [Related]
12. Longitudinal changes in health-related quality of life according to clinical course among patients with non-tuberculous mycobacterial pulmonary disease: a prospective cohort study.
Kwak N; Kim SA; Choi SM; Lee J; Lee CH; Yim JJ
BMC Pulm Med; 2020 May; 20(1):126. PubMed ID: 32381080
[TBL] [Abstract][Full Text] [Related]
13. Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease.
Moon SM; Jhun BW; Baek SY; Kim S; Jeon K; Ko RE; Shin SH; Lee H; Kwon OJ; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Koh WJ
Respir Med; 2019 May; 151():1-7. PubMed ID: 31047103
[TBL] [Abstract][Full Text] [Related]
14. Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Cough and Sputum in Patients with COPD.
Rebelo P; Oliveira A; Paixão C; Valente C; Andrade L; Marques A
Int J Chron Obstruct Pulmon Dis; 2020; 15():201-212. PubMed ID: 32099345
[TBL] [Abstract][Full Text] [Related]
15. Effects of pain on depression, sleep, exercise tolerance, and quality of life in patients with nontuberculous mycobacterial pulmonary disease.
Mori K; Tabusadani M; Yamane K; Takao S; Kuroyama Y; Matsumura Y; Ono K; Kawahara K; Omatsu S; Fujiwara K; Furuuchi K; Morimoto K; Kimura H; Senjyu H
Medicine (Baltimore); 2021 Jun; 100(23):e26249. PubMed ID: 34115015
[TBL] [Abstract][Full Text] [Related]
16. Clinical phenotypes of nontuberculous mycobacterial disease by cluster analysis based on pulmonary function.
Hamao N; Ito I; Oi I; Shirata M; Nishioka K; Hayashi Y; Imai S; Hirai T
Respir Med; 2024; 225():107600. PubMed ID: 38490432
[TBL] [Abstract][Full Text] [Related]
17. Nontuberculous mycobacterial pulmonary disease and associated risk factors in China: A prospective surveillance study.
Tan Y; Deng Y; Yan X; Liu F; Tan Y; Wang Q; Bao X; Pan J; Luo X; Yu Y; Cui X; Liao G; Ke C; Xu P; Li X; Zhang C; Yao X; Xu Y; Li T; Su B; Chen Z; Ma R; Jiang Y; Ma X; Bi D; Ma J; Yang H; Li X; Tang L; Yu Y; Wang Y; Song H; Liu H; Wu M; Yang Y; Xue Z; Li L; Li Q; Pang Y
J Infect; 2021 Jul; 83(1):46-53. PubMed ID: 34048821
[TBL] [Abstract][Full Text] [Related]
18. Impaired cough-related quality of life in patients with nontuberculous mycobacteriosis.
Nakayasu H; Shirai T; Hirai K; Suzuki T; Akamatsu T; Sakurai S; Asada K
Respir Investig; 2023 Jan; 61(1):45-51. PubMed ID: 36195550
[TBL] [Abstract][Full Text] [Related]
19. Nonpharmacological treatment for patients with nontuberculous mycobacterial lung disease.
Lan CC; Lai SR; Chien JY
J Formos Med Assoc; 2020 Jun; 119 Suppl 1():S42-S50. PubMed ID: 32499207
[TBL] [Abstract][Full Text] [Related]
20. Bronchoscopy for the diagnosis of nontuberculous mycobacterial pulmonary disease: Specificity and diagnostic yield in a retrospective cohort study.
Tomishima Y; Urayama KY; Kitamura A; Okafuji K; Jinta T; Nishimura N; Tamura T
Respir Investig; 2022 May; 60(3):355-363. PubMed ID: 34998716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
